✦ LIBER ✦

The JAK2V617Fmutation: no impact on circulating hematopoietic progenitors in myeloproliferative disorders

✍ Scribed by Michaela Wappl; Eva Jaeger; Raiko Kusec; Ilse Schwarzinger; Klaus Geissler; Leopold Oehler

Publisher: Springer
Year: 2008
Tongue: English
Weight: 82 KB
Volume: 87
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-007-0428-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

JAK2V617F mutation can occur exclusively

JAK2V617F mutation can occur exclusively in the erythroid lineage and be absent in granulocytes and progenitor cells in classic myeloproliferative disorders

✍ Barbara K. Zehentner; Michael R. Loken; Denise A. Wells 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB 👁 1 views

The impact of JAK2 non-receptor tyrosine

The impact of JAK2 non-receptor tyrosine kinase mutation on the mobilization of hematopoietic stem cells into peripheral blood of patients with Philadelphia chromosome-negative myeloproliferative disorders

✍ Supattra Kannim; Chirayu U. Auewarakul 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 97 KB 👁 2 views

Impact of air staging on the fate of NO

Impact of air staging on the fate of NO and N2O in a circulating fluidized-bed combustor

✍ X.S. Wang; B.M. Gibbs; M.J. Rhodes 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 630 KB

This paper presents an experimental investigation of the influence of combustion-air staging on the formation and reduction of NO and N20 from coal combustion, carried out in a 6.2-m-tall and 0.161-m i.d. circulating fluidized-bed (CFB) combustor. The main operating parameters examined were secondar

Personality disorders have no excessivel

Personality disorders have no excessively negative impact on therapist-rated therapy process in the cognitive and behavioural treatment of Axis I anxiety disorders

✍ Laura Dreessen; Arnoud Arntz 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 3 views

The impact of DSM-III-R personality pathology on the Axis I therapy process was studied in 70 outpatients who received cognitive and/or behavioural therapy for an Axis I anxiety disorder. The Axis I therapy process was evaluated by the therapist. DSM-III-R personality pathology was assessed first by